Members Login
    Remember Me  
Post Info TOPIC: Dravet Syndrome Market Size, Share, Growth & Trends, 2027

Senior Member

Status: Offline
Posts: 167
Dravet Syndrome Market Size, Share, Growth & Trends, 2027

Dravet Syndrome Market Overview

Dravet syndrome is a severe form of the epileptic disorder that initiates in the first year of an otherwise healthy infant. Around 85% of children with Dravet syndrome develop myoclonic seizures between 1-5 years.

Many factors such as the development of new drugs and therapies, rising R&D expenditure, unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are propelling the growth of the global Dravet syndrome market.

It is estimated that the Dravet syndrome market is expected to grow at a CAGR of 8.5% during the forecast period, 2017-2023.

Request Free Sample Copy at:

Dravet Syndrome Market Segmentation

The global Dravet syndrome market size is segmented on the basis of the type of seizures, diagnosis, treatment & management, and end-user.

On the basis of the type of seizures, the market is classified as myoclonic seizures, atonic seizures, partial seizures, absence seizures, tonic clonic seizures, photosensitive seizures, and others.

On the basis of the diagnosis, the market is classified as magnetic resonance imaging (MRI), electroencephalography (EEG), SCN1A testing, and others.

On the basis of the treatment & management, the market is classified as seizure medications, ketogenic diet, vagus nerve stimulation (VNS), and others. The seizure medications segment is further classified into clobazam, stiripentol, sodium valproate, and others.

On the basis of the end-user, the market is segmented into pharmaceutical companies, hospitals, diagnostic laboratories, academic and research institutes, and others.

Dravet Syndrome Market Regional Analysis

The Americas dominate the Dravet syndrome market owing to the presence of a large number of leading market players, rising development of new drugs, and high healthcare expenditure. Various U.S.-based pharmaceutical companies such as Zogenix, Inc., Insys Therapeutics, Inc., and OPKO Health, Inc. are continuously putting efforts to come up with novel drugs to control Dravet syndrome and related complications.

Europe holds the second position in the Dravet syndrome market. It is expected that the support provided by the government authorities for research & development and initiatives taken to improve the reimbursement policies in healthcare is likely to drive the European market.

Asia Pacific is the fastest growing Dravet syndrome market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare, in the years 2015-2016, the total health expenditure in Australia was USD 170.4 billion, which is recorded to be 3.6% higher than the expenditure of 2014-2015.

The Middle East & Africa holds the lowest share of the global market due to lack of technical knowledge and poor medical facilities.

Dravet Syndrome Market Players

Globus Medical, Inc. (U.S.)

Depuy Synthes Inc. (Johnson & Johnson) (U.S.)

Smith & Nephew plc. (UK)

NuVasive, Inc. (U.S.)

Stryker Corporation (U.S.)

Integra LifeSciences Holdings Corporation (U.S.)

Zimmer Biomet Holdings, Inc. (U.S.)

Medtronic, plc (Ireland)

Wright Medical Group N.V. (Netherlands)

The Orthopedic Implant Company (U.S.)

Aesculap Implant Systems (U.S.)

Conmed Corporation (U.S.)

BioTek Instruments, Inc. (U.S.)

Arthrocare Corporation (U.S.)

among others are some key companies in the global dravet syndrome that are listed by MRFR for market research.

Browse Detailed TOC with COVID-19 Impact Analysis at:

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071


Page 1 of 1  sorted by
Quick Reply

Please log in to post quick replies.

Tweet this page Post to Digg Post to

Create your own FREE Forum
Report Abuse
Powered by ActiveBoard